Physician profile
Jeffrey E Kerlan
NPI 1154369932
$6,847.44
in general payments reported to CMS, 2019-2025
29 companies · $757 in 2025
The $757 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,724 · 2020: $165 · 2021: $292 · 2022: $384 · 2023: $1,181 · 2024: $1,346 · 2025: $757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,651 · Food and Beverage: $1,632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,651.00 |
| Food and Beverage | $1,632.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,333.51 | 2019-2025 | Farapulse, Watchman Flx, General - Ep |
| Abbott Laboratories | $926.86 | 2019-2025 | Aveir, Tacticath Ablation Catheter, Sensor Enabled, Agilis |
| Medtronic Vascular, INC. | $801.78 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $400.26 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $145.17 | 2019-2025 | Eliquis, Camzyos |
| Biotronik INC. | $144.01 | 2025 | Pamira, Amvia Edge, Acticor 7 Vr-T Dx |
| Sanofi-Aventis U.S. LLC | $136.93 | 2019-2023 | |
| Actelion Pharmaceuticals US, INC. | $108.15 | 2019 | |
| Medtronic, INC. | $97.99 | 2021-2023 | Micra, Cobalt Dr Mri Surescan |
| Biosense Webster, INC. | $90.64 | 2019-2024 | Carto 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.21 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $67.03 | 2021-2025 | Wainua |
| Pfizer INC. | $63.76 | 2021-2022 | |
| Amgen INC. | $61.70 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $54.77 | 2019-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $40.11 | 2019 | |
| Cordis US Corp. | $37.53 | 2025 | |
| Philips North America LLC | $37.17 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $29.71 | 2022-2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.11 | 2020-2021 | |
| Irhythm Technologies, INC. | $22.94 | 2024 | Zio Monitor, Zio Xt Patch |
| Csl Behring | $22.77 | 2022 | |
| Novo Nordisk INC | $20.66 | 2025 | Wegovy |
| Cvrx, INC. | $19.83 | 2021 | |
| Vifor Pharma, INC. | $19.70 | 2019 | |
| Kiniksa Pharmaceuticals, Ltd. | $17.64 | 2023 | Arcalyst |
| Portola Pharmaceuticals, LLC | $16.21 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $13.14 | 2023 | Inpefa |
| G Medical Diagnostic Services, INC. | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Kerlan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.